More From Eric Dixon at

Support Independent Investigations With Bitcoin:
Send Bitcoin Here: 171GMeYRD7CaY6tkXs8dSTjLbAtFazxhVL

Top 50 Twitter Rank of Worldwide Startup Advisors For Much of 2014
. Go to my professional site for solutions to your legal, business and strategic problems. The only lawyer who is a co-inventor of multiple, allowed-for-grant patents on blockchain technology!!! Blockchain and Digital Currency Protocol Development --
Top Strategic Judgment -- When You Need A Fixer -- Explore Information Protection and Cryptographic Security -- MUST-WIN: JUST DON'T LOSE -- SURVIVE!: Under Investigation? Being Sued? Handling Extreme Stress -- Corporate Issues -- Startup Issues -- Investor Issues -- Contracts To Meet Your Needs -- Opposition Research -- Intellectual Property, Media and Reputation Issues -- Independent, top-notch legal, strategic and personal advice -- Extensive ghostwriting, speechwriting, book writing, issue research, press and crisis management services. Listed by American Bar Association's Law Bloggers (Blawgers). Contact European Union audiences: This site uses a third party site administrator which may use cookies but this site is intended for AMERICAN clients and prospective clients only!

Sunday, November 13, 2011

Down's Syndrome Test Uses Abortion As Cure

A scandal-ridden company is marketing a controversial new test to identify fetuses with the chromosonal defect (Trisomy 21).  But rather than cure the genetic defect, the test facilitates strategic abortions: that is, it allows for screening fetuses for the defect so that parents can abort the unwanted child.

The test's proponent is Sequenom Inc., headquartered in San Diego, CA.  Sequenom previously suffered a catastrophic stock price drop in 2009 when it was revealed that several of its scientists were fudging scientific test data; even as the broader stock market was recovering in the spring of 2009, Sequenom's stock plunged from $13 to $3.  

Eric Dixon is a New York investigative lawyer with a strong background in complex litigation, securities compliance and business transactions.

No comments:

Post a Comment